A New ACR
Anti IL-17 on Entheseal Biopsy in PsA
axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure
Best Things I Saw Today in PsA
Cycling vs Switching after TNFi Failure in axSpA
Improvements in Pain and Fatigue in Bimekizumab
Long-term Safety Profile of Bimekizumab in axSpA and PsA
Sonelokimab in PsA: Phase 2 Data
Treating SpA
Information
- Show
- FrequencyUpdated weekly
- Published24 November 2024 at 00:25 UTC
- Length33 min
- Episode1.3K
- RatingClean